EDN1 and Stroke: We thought it would be important to establish the temporal evolution of microglia activation, astrocytosis, oligodendrocyte damage, and Nogo-A immunoreactivity during the first month after ET-1-induced stroke, as a morphological basis for further functional studies seeking new neuroprotective drugs.